Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Receivables (2023 - 2025)

Bioregenx's Receivables history spans 3 years, with the latest figure at $39718.0 for Q4 2025.

  • Quarterly results put Receivables at $39718.0 for Q4 2025, down 80.53% from a year ago — trailing twelve months through Dec 2025 was $39718.0 (down 80.53% YoY), and the annual figure for FY2025 was $39718.0, down 80.53%.
  • Receivables for Q4 2025 was $39718.0 at Bioregenx, down from $62610.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $203992.0 in Q4 2024 to a low of $10943.0 in Q2 2024.
  • The 3-year median for Receivables is $21115.0 (2025), against an average of $53859.0.
  • Peak annual rise in Receivables hit 222.03% in 2025, while the deepest fall reached 80.53% in 2025.
  • Year by year, Receivables stood at $104581.0 in 2023, then soared by 95.06% to $203992.0 in 2024, then tumbled by 80.53% to $39718.0 in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $39718.0, $62610.0, and $21115.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.